Possible fourth death tied to Tysabri
Biogen Idec has told the FDA a fourth patient may have contracted a potentially deadly brain disease after taking the ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.